Known hypersensitivity to vinorelbine or other vinca alkaloids or to any of the constituents.
Disease significantly affecting absorption.
Previous significant surgical resection of stomach or small bowel.
Neutrophil count <1500/mm3 or severe infection current or recent (within 2 weeks).
Platelet count <100000/mm3.
Lactation.
Patients requiring long-term oxygen therapy.
In combination with yellow fever vaccine.
Severe hepatic insufficiency.
Pregnancy.